Nature Structural and Molecular Biology—AEP可能是治疗帕金森病的潜在药物靶点

点评:最近科学家发现一个酶—AEP,其在阿尔茨海默病和帕金森病中都发挥着重要的作用。研究人员发现AEP可以将α-synuclein剪切为更具有毒性的片段,提示AEP的抑制剂可以治疗帕金森病。

A new study has found an enzyme that drives neurotoxicity in both Alzheimer's and Parkinson's disease. Blocking the action of this enzyme may prevent these conditions from developing, so the research may have found a new drug target.

It is currently estimated that more than 5 million people in the United States are living withAlzheimer's disease, and as many as 1 in 3 elders are said to die with the condition, or another form of dementiaParkinson's disease also affects approximately 60,000 U.S. adults every year.

Both diseases are neurodegenerative, meaning that brain cells progressively and irreversibly degenerate until they eventually die.

Previous research carried out by Dr. Ye and colleagues found an enzyme called asparagine endopeptidase (AEP), which makes tau clumpier and more toxic. The new research hypothesized that AEP would have the same enhancing effect on alpha-synuclein.

As expected, Dr. Ye and team found that AEP drives the aggregation of alpha-synuclein and increases its neurotoxicity. In the mouse model designed by the researchers, AEP-induced neurotoxicity lead to a loss of neurons and motor deficits.


The researchers also found that AEP has a scissor-like, "cleaving" effect on human alpha-synuclein. Cleaved fragments of alpha-synuclein were found to be likelier to form clumps than the full-length form of the protein. When introduced in the cells or brains of mice, the neurotoxicity of the cleaved protein was higher.

Additionally, the researchers mutated the protein so that AEP could not cleave it, and they found that the uncut protein was less toxic.


Furthermore, Dr. Ye and colleagues found cleaved fragments of alpha-synuclein in brain tissue samples from people with Parkinson's disease, but not in samples from healthy controls.


In the healthy control samples, the researchers found AEP exclusively in lysosomes, which are tiny organelles within the cell that act as its "digestive system." But in the tissue samples of people with Parkinson's disease, AEP overflowed into other parts of the cell.


These findings could point to a new target for a potential anti-Parkinson's drug. Trials in animal models have already shown that an AEP-inhibiting drug preserves memory and may have a preventive effect against Alzheimer's disease.


Although the researchers note that AEP is not the only enzyme that breaks down alpha-synuclein, thus making it more toxic, Dr. Ye and team are also planning to test AEP-inhibiting drugs in animals with Parkinson's disease.


Even though there are various differences between the two conditions on a genetic and structural level, a team of scientists at Emory University in Atlanta, GA, may have found an enzyme that triggers both of them. This newly discovered enzyme could be a target for a potential drug for Parkinson's disease.

The new study was led by Keqiang Ye, Ph.D., and the findings were published in the journal Nature Structural and Molecular Biology.

经典文章回顾

帕金森病患者的康复治疗

帕金森病患者的疾病预防和保健常识

10条老年性痴呆患者的护理常识

四条建议教老年人预防老年性痴呆

老年性痴呆患者的饮食禁忌和饮食调理

2016年阿尔茨海默病10大研究进展

2016年帕金森病10大研究进展

你对老年性痴呆症到底懂多少?

地中海饮食最健康的神经科学分析

八种食物提高记忆力,增强脑活力!

预防老年性痴呆症,先从这些小事做起!

睡眠不足增加肥胖风险的神经科学解释

运动是大脑的最佳保健品

预防痴呆和脑中风,减少PM2.5是我们可以做的

益生菌也能够治疗痴呆、抑郁症和精神分离症?

喜欢我,关注我

拉到最上方标题下,点击上方蓝字关注

搜索公众号名称:神经科学临床和基础

也请你推荐给你身边的医学朋友,感谢你~


    本站仅按申请收录文章,版权归原作者所有
    如若侵权,请联系本站删除
    觉得不错,分享给更多人看到